KE3289A - 1,4-dioxido-3-methyl-quinoxaline(2)carboxamides - Google Patents

1,4-dioxido-3-methyl-quinoxaline(2)carboxamides

Info

Publication number
KE3289A
KE3289A KE3289A KE328983A KE3289A KE 3289 A KE3289 A KE 3289A KE 3289 A KE3289 A KE 3289A KE 328983 A KE328983 A KE 328983A KE 3289 A KE3289 A KE 3289A
Authority
KE
Kenya
Prior art keywords
dioxido
carboxamides
quinoxaline
methyl
Prior art date
Application number
KE3289A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH63476A external-priority patent/CH627174A5/de
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of KE3289A publication Critical patent/KE3289A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52Oxygen atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/137Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KE3289A 1976-01-20 1983-05-20 1,4-dioxido-3-methyl-quinoxaline(2)carboxamides KE3289A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH63476A CH627174A5 (en) 1976-01-20 1976-01-20 Process for the preparation of quinoxaline di-N-oxide derivatives
CH1492076 1976-11-26

Publications (1)

Publication Number Publication Date
KE3289A true KE3289A (en) 1983-06-17

Family

ID=25685198

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3289A KE3289A (en) 1976-01-20 1983-05-20 1,4-dioxido-3-methyl-quinoxaline(2)carboxamides

Country Status (21)

Country Link
US (1) US4092415A (pl)
JP (1) JPS5289683A (pl)
AU (1) AU515192B2 (pl)
BR (1) BR7700355A (pl)
CA (1) CA1108143A (pl)
DE (1) DE2701707C2 (pl)
DK (1) DK141509B (pl)
EG (1) EG13191A (pl)
ES (1) ES455158A1 (pl)
FR (1) FR2338935A1 (pl)
GB (1) GB1569034A (pl)
HK (1) HK41283A (pl)
IL (1) IL51292A (pl)
KE (1) KE3289A (pl)
MY (1) MY8400251A (pl)
NL (1) NL7700581A (pl)
NZ (1) NZ183118A (pl)
SE (1) SE427928B (pl)
SG (1) SG28883G (pl)
SU (1) SU890961A3 (pl)
YU (2) YU39221B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT7869686A0 (it) * 1978-11-24 1978-11-24 Loranze Torino A Procedimento di preparazione di 2metil 3 bidrossietilcarbamollchinossalina i.4 di n ossido puroed altri composti ad esso simili
US4418063A (en) * 1978-12-19 1983-11-29 Ciba-Geigy Corporation Growth promoting quinoxaline-di-N-oxide carboxamides
US4254120A (en) * 1978-12-19 1981-03-03 Ciba-Geigy Corporation Growth promoting quinoxaline-di-N-oxide carboxamides
DE3133888A1 (de) * 1981-08-27 1983-03-10 Bayer Ag Wirkstoffkombination aus kitasamycin und chinoxalin-di-n-oxiden
JPH06701B2 (ja) * 1983-12-01 1994-01-05 旭化成工業株式会社 動物用組成物
ES2707876T3 (es) * 2010-12-20 2019-04-05 Dsm Ip Assets Bv Uso de moléculas orgánicas de nitrooxi en pienso para reducir la emisión de metano en rumiantes
EP2644038A1 (en) * 2012-03-26 2013-10-02 DSM IP Assets B.V. Use of para nitro amino derivatives in feed for reducing meth-ane emission in ruminants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670935C3 (de) * 1967-10-04 1975-12-04 Bayer Ag, 5090 Leverkusen 2-Methyl-3-carbonsäureamidochinoxalin-1,4-dl-N-oxide, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende antibakterielle Mittel
GB1223720A (en) 1968-10-30 1971-03-03 Ici Ltd Growth promotion
US3635972A (en) * 1969-07-22 1972-01-18 Pfizer 3-methyl-2-quinoxalinecarboxamidedi-n-oxides

Also Published As

Publication number Publication date
US4092415A (en) 1978-05-30
ES455158A1 (es) 1978-04-01
JPS6135985B2 (pl) 1986-08-15
FR2338935A1 (fr) 1977-08-19
YU153482A (en) 1982-10-31
GB1569034A (en) 1980-06-11
YU40081B (en) 1985-06-30
DK20277A (pl) 1977-07-21
DK141509B (da) 1980-04-08
SG28883G (en) 1984-04-19
CA1108143A (en) 1981-09-01
FR2338935B1 (pl) 1979-03-23
DE2701707A1 (de) 1977-07-21
YU13577A (en) 1982-10-31
YU39221B (en) 1984-08-31
SE427928B (sv) 1983-05-24
HK41283A (en) 1983-10-21
IL51292A0 (en) 1977-03-31
BR7700355A (pt) 1977-09-20
DE2701707C2 (de) 1986-05-22
SU890961A3 (ru) 1981-12-15
NL7700581A (nl) 1977-07-22
EG13191A (en) 1980-12-31
JPS5289683A (en) 1977-07-27
AU515192B2 (en) 1981-03-19
NZ183118A (en) 1979-12-11
IL51292A (en) 1981-06-29
DK141509C (pl) 1980-09-29
AU2144377A (en) 1978-07-27
MY8400251A (en) 1984-12-31
SE7700529L (sv) 1977-07-21

Similar Documents

Publication Publication Date Title
PH13932A (en) 1,2,3,4-tetrahydro-napthalenes
CY1155A (en) 2-piperazinyl-6,7-dimethoxyquinazolines
MY8200265A (en) 5,9-or 6,9-epoxyprostaglandins
GB1524917A (en) Gona-1,9(10)-dienes
GB1542361A (en) 1,4-benzo-dioxan derivatives
GB1556570A (en) 1,5-disubstituted - 2 - pyrrolidones
GB1542569A (en) 2-substituted-15-heteroaryl-16,17,18,19,20-pentanor-prostaglandins
ZA772548B (en) 1,3-dihydro-heteroarylspiro(isobenzofuran)s
PH15708A (en) 2,6-methanol-2h-1-benzoxocins
NZ183875A (en) -(2-alkylphenyl)-3-methyl-5-heter-oaryl-1,3,5-triazapenta-1,4-dienes
SG28883G (en) 1,4-dioxido-3-methyl-quinoxaline(2)carboxamides
GB1556279A (en) 3,7-disubstituted-3-cephem-4-carboxylic acids
NZ183846A (en) 1,2,3,3a,4,5-hexahydro-6h-indolo(3,2,1-de) (1,5)-naphthyridines
IL52152A (en) 3,5,5-trimethylhexonoyl ferrocene
PH14105A (en) 1,2,3-thiadiazol-5-yl-ureas
AU2468877A (en) 1,4 -dicyanobytene
ZA774515B (en) O-ethyl-s-n-propyl-o-2,2,2-trihaloethylphosphorothiolates(or thionothiolates)
GB1537635A (en) 15,16-dihydroxyprostaglandins
GB1538368A (en) 1,3,4,6-tetrathia and tetraselena-2,5-dihetero-pentalene compounds
NZ185419A (en) 1,2,3,4-tetrahydro-9h-pyrrolo(3,4-b)quinolin-9-ones
GB1547729A (en) 1-phenyl-4-acetoxy-1,2-dihydroquinolin-2-ones
GB1544339A (en) 2,3-dihydro-2-oxo-3-benzo(b)thiophenecarboxamides
AU3191777A (en) 1,4-oxathianes
AU3178777A (en) Substituted 4,5-dihydroxy-imidazolidine-2-thiones
GB1554045A (en) 13,14-didehydroprostaglandins